Cencora/$COR
1D1W1MYTD1Y5YMAX
Capital at risk
About Cencora
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
- Ticker
- $COR
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 49,000
- Headquarters
- Conshohocken, United States
- Website
- www.cencora.com
Cencora Metrics
BasicAdvanced
$62B
24.12
$13.46
0.57
$2.40
0.74%
Price and volume
Market cap
$62B
Beta
0.57
52-week high
$377.54
52-week low
$244.82
Average daily volume
1.4M
Dividend rate
$2.40
Financial strength
Current ratio
0.935
Quick ratio
0.477
Long term debt to equity
353.312
Total debt to equity
361.93
Dividend payout ratio (TTM)
17.83%
Interest coverage (TTM)
8.78%
Profitability
EBITDA (TTM)
5,547.404
Gross margin (TTM)
3.96%
Net profit margin (TTM)
0.79%
Operating margin (TTM)
1.35%
Effective tax rate (TTM)
26.82%
Revenue per employee (TTM)
$6,790,000
Management effectiveness
Return on assets (TTM)
3.56%
Return on equity (TTM)
96.87%
Valuation
Price to earnings (TTM)
24.12
Price to revenue (TTM)
0.189
Price to book
19.13
Price to tangible book (TTM)
-3.19
Price to free cash flow (TTM)
15.511
Free cash flow yield (TTM)
6.45%
Free cash flow per share (TTM)
20.933
Dividend yield (TTM)
0.74%
Forward dividend yield
0.74%
Growth
Revenue change (TTM)
5.09%
Earnings per share change (TTM)
39.11%
3-year revenue growth (CAGR)
9.36%
10-year revenue growth (CAGR)
8.68%
3-year earnings per share growth (CAGR)
18.02%
10-year earnings per share growth (CAGR)
6.18%
3-year dividend per share growth (CAGR)
7.06%
10-year dividend per share growth (CAGR)
6.02%
What the Analysts think about Cencora
Analyst ratings (Buy, Hold, Sell) for Cencora stock.
Analyst projections of the future price of Cencora stock.
Bulls say / Bears say
Cencora’s board authorized a new $2 billion share repurchase program and raised the lower end of its fiscal 2026 EPS guidance, underscoring management’s confidence in the firm’s cash flow generation (Reuters)
Following its August 5 Q3 report, Cencora lifted its annual adjusted profit forecast after delivering an EPS beat driven by robust specialty-medicine demand, signaling strong underlying margin expansion (Reuters)
Despite missing Q2 estimates, Cencora raised its full-year profit projection on May 6, citing resilient demand for high-margin specialty therapies across its U.S. healthcare solutions segment (Reuters)
Q2 2026 revenue of $78.4 billion missed LSEG consensus of $81.09 billion and adjusted EPS of $4.75 came in below the $4.81 estimate, underscoring near-term demand weakness in Cencora’s core U.S. distribution business (Reuters)
Cencora pared its full-year revenue growth outlook after slower U.S. sales, with manufacturers’ cuts to branded drug prices shaving approximately $2 billion off Q2 revenue, highlighting pricing pressure in its largest segment (Reuters)
Shares are down roughly 9 percent year-to-date, reflecting investor skepticism after consecutive quarters of softer top-line trends (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 20 Aug 2026.
Cencora Financial Performance
Revenues and expenses
Cencora Earnings Performance
Company profitability
Upcoming events
No upcoming events
Cencora News
AllArticlesVideos
Funds containing Cencora
AllEURUSDGBP
Fund name | Fund size | $COR weighting |
|---|---|---|
iShares MSCI World Health Care Sector Advanced€CBUF | €606M | 1.68% |
iShares Edge MSCI World Minimum Volatility$MVOL | $2.6B | 1.29% |
iShares Edge MSCI World Minimum Volatility€IQQ0 | €2.3B | 1.29% |
iShares Edge MSCI World Minimum Volatility£MINV | £1.9B | 1.29% |
iShares S&P 500 Health Care Sector€IUHE | €125M | 1.03% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.